So we’ve got 4 out of 7. Who wouldn’t ask their Oncologist for Azer-Cel rather than 4-5 lines of other treatments first. This will become standard of care. No Oncologist would give their patients inferior treatment. There is no cost saving using 4 or 5 other therapies on the way through .
Let’s hope this starts the re-rate that’s long over due . 2025 the year IMU produces the data to justify the long journey !
Anybody know if RAC has their ethics approval yet?
Ann: Azer-cel demonstrates two additional Complete Responses, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $255.7K | 18.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 18692454 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4515891 | 5 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |